QELBREE 150 mg/1

QELBREE 150 mg/1 is an extended-release capsule containing viloxazine hydrochloride, used for managing certain conditions. This medication is designed for oral administration and is manufactured by Supernus Pharmaceuticals, Inc.

QELBREE 150 mg/1 is primarily used for managing symptoms associated with specific mental health conditions. Viloxazine hydrochloride, the active ingredient, is often prescribed to help improve focus and reduce impulsivity. This medication is designed to provide extended relief, making it suitable for daily use. What is QELBREE used for? It is commonly used to manage symptoms that require long-term treatment.

Common effects of QELBREE 150 mg/1 may include changes in appetite, sleep disturbances, and mild gastrointestinal discomfort. Some users may experience dizziness or headaches, especially when starting the medication. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

QELBREE 150 mg/1 should be stored at room temperature and kept out of reach of children. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Do not crush or chew the extended-release capsules, as this can affect the medication's release mechanism.

QELBREE 150 mg/1 may interact with certain medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other central nervous system depressants should be used with caution while taking this medication.